Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03QAO
|
|||
| Former ID |
DIB001346
|
|||
| Drug Name |
AZD-9742
|
|||
| Indication | MRSA infection [ICD-11: 1D01.0Y; ICD-10: A49.02; ICD-9: 41.12] | Phase 1 | [1] | |
| Company |
AstraZeneca plc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H26FN5O3
|
|||
| Canonical SMILES |
C1CN(CC(C1NCC2=CC3=C(C=N2)OCCO3)F)CCN4C(=O)C=CC5=C4C=C(C=C5)C#N
|
|||
| InChI |
1S/C25H26FN5O3/c26-20-16-30(7-8-31-22-11-17(13-27)1-2-18(22)3-4-25(31)32)6-5-21(20)29-14-19-12-23-24(15-28-19)34-10-9-33-23/h1-4,11-12,15,20-21,29H,5-10,14,16H2/t20-,21+/m1/s1
|
|||
| InChIKey |
JYJKOWWSKTWAJA-RTWAWAEBSA-N
|
|||
| CAS Number |
CAS 1033748-95-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01030224) This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.